Chang, Y.-C.; Wang, C.-H.; Tang, C.-C.; Lin, Y.-L.; Lai, Y.-H.; Kuo, C.-H.; Hsu, B.-G.
Serum Malondialdehyde-Modified Low-Density Lipoprotein Level May Be a Biomarker Associated with Aortic Stiffness Among Patients Undergoing Peritoneal Dialysis. Life 2024, 14, 1385.
https://doi.org/10.3390/life14111385
AMA Style
Chang Y-C, Wang C-H, Tang C-C, Lin Y-L, Lai Y-H, Kuo C-H, Hsu B-G.
Serum Malondialdehyde-Modified Low-Density Lipoprotein Level May Be a Biomarker Associated with Aortic Stiffness Among Patients Undergoing Peritoneal Dialysis. Life. 2024; 14(11):1385.
https://doi.org/10.3390/life14111385
Chicago/Turabian Style
Chang, Yu-Chi, Chih-Hsien Wang, Chi-Chong Tang, Yu-Li Lin, Yu-Hsien Lai, Chiu-Huang Kuo, and Bang-Gee Hsu.
2024. "Serum Malondialdehyde-Modified Low-Density Lipoprotein Level May Be a Biomarker Associated with Aortic Stiffness Among Patients Undergoing Peritoneal Dialysis" Life 14, no. 11: 1385.
https://doi.org/10.3390/life14111385
APA Style
Chang, Y.-C., Wang, C.-H., Tang, C.-C., Lin, Y.-L., Lai, Y.-H., Kuo, C.-H., & Hsu, B.-G.
(2024). Serum Malondialdehyde-Modified Low-Density Lipoprotein Level May Be a Biomarker Associated with Aortic Stiffness Among Patients Undergoing Peritoneal Dialysis. Life, 14(11), 1385.
https://doi.org/10.3390/life14111385
